The Mission Boost Grants (MBG) from the American Cancer Society support current and past ACS grantees specifically for the translation of their research to human testing. MBGs are opportunities for American Cancer Society (ACS) grantees to seek additional, or “boost,” resources for innovative, high-risk/high-reward projects. MBGs offer 2 stages of funding:
- Stage I requires the investigator to develop outcome-specific, unequivocal milestones that reduce the risks of studying a new drug, device, or procedure in patients.
- Stage II supports testing in cancer patients.
Stage I Mission Boost
Applicants may propose up to 2 years with up to $100,000 a year for direct costs, plus 20% indirect costs.
Stage II Mission Boost
Applicants may propose up to 18 months and $500,000 for direct costs, plus 20% indirect costs.
Applications close annually on April 1 and October 15. The next applications close on April 1, 2024.
April 1, 2024